Gene expression analysis approach to establish possible links between Parkinson's disease, cancer and cardiovascular diseases.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  CNS and Neurological Disorders - Drug Targets

• Publication date

  2014-09-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1871527313666141023122803PMID 25345512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteomics approaches to understand linkage between Alzheimer's disease and type 2 diabetes mellitus.

  2014cited by this paper
• Establishing genomic/transcriptomic links between Alzheimer's disease and type 2 diabetes mellitus by meta-analysis approach.

  2014cited by this paper
• Vascular hyperpermeability and aging.

  2014cited by this paper
• Hypoxia-inducible factor 1 and cardiovascular disease.

  2014cited by this paper
• The meaning, measurement and modification of hypoxia in the laboratory and the clinic.

  2014cited by this paper
• Over-expression of hypoxia-inducible factor-1 alpha in vitro protects the cardiac fibroblasts from hypoxia-induced apoptosis

  2014cited by this paper
• Neurological applications for myocardial MIBG scintigraphy

  2013cited by this paper
• Neurological applications for myocardial MIBG scintigraphy.

  2013cited by this paper
• Vitamin and Mineral Supplements in the Primary Prevention of Cardiovascular Disease and Cancer: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force

  2013cited by this paper
• ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro.

  2013cited by this paper
• Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation.

  2013cited by this paper
• Different actions of endothelin-1 on chemokine production in rat cultured astrocytes: reduction of CX3CL1/fractalkine and an increase in CCL2/MCP-1 and CXCL1/CINC-1

  2013cited by this paper
• Molecular Biomarkers of Vascular Dysfunction in Obstructive Sleep Apnea

  2013cited by this paper
• Biomarkers in Parkinson's disease (recent update).

  2013cited by this paper
• Atorvastatin protects against deleterious cardiovascular consequences induced by chronic intermittent hypoxia

  2013cited by this paper
• Mitochondria as an easy target to oxidative stress events in Parkinson's disease.

  2012cited by this paper
• Imaging beyond the striatonigral dopaminergic system in Parkinson's disease.

  2012cited by this paper
• Hypoxia regulation of ATP13A2 (PARK9) gene transcription

  2012cited by this paper
• Families with Parkinson disease and cancer.

  2012cited by this paper
• The role of hypoxia-inducible factor 1 in atherosclerosis

  2012cited by this paper
• A synopsis on the role of tyrosine hydroxylase in Parkinson's disease.

  2012cited by this paper
• BRCA2 Variants and cardiovascular disease in a multi-ethnic study

  2012cited by this paper
• DNA Damage and Repair in Atherosclerosis: Current Insights and Future Perspectives

  2012cited by this paper
• Shared predispositions of parkinsonism and cancer: a population-based pedigree-linked study.

  2012cited by this paper
• Dynamics of adherens junctions in epithelial establishment, maintenance, and remodeling

  2011cited by this paper
• Meta-analysis of the relationship between Parkinson disease and melanoma

  2011cited by this paper
• Parkinson Disease and Malignant Melanoma in First-degree Relatives of Patients With Early-onset Melanoma

  2011cited by this paper
• Fine-Tuning Roles of Endogenous Brain-Derived Neurotrophic Factor, TrkB and Sortilin in Colorectal Cancer Cell Survival

  2011cited by this paper
• Diagnostic markers for Parkinson's disease.

  2011cited by this paper
• BRCA1 is an essential regulator of heart function and survival following myocardial infarction

  2011cited by this paper
• Expression analysis of dopaminergic neurons in Parkinson’s disease and aging links transcriptional dysregulation of energy metabolism to cell death

  2011cited by this paper
• Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics

  2011cited by this paper
• Clinical trials of antioxidants as cancer prevention agents: past, present, and future.

  2011cited by this paper
• Losartan abolishes oxidative stress induced by intermittent hypoxia in humans

  2011cited by this paper
• Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning.

  2011cited by this paper
• Parkinson's Disease-Related Protein, α-Synuclein, in Malignant Melanoma

  2010cited by this paper
• Steroids‐Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders

  2010cited by this paper
• Parkinson’s disease and cancer risk: a systematic review and meta-analysis

  2010cited by this paper
• The role of BRCA1 in DNA damage response

  2010cited by this paper
• Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling.

  2010cited by this paper
• Association of pyridoxal kinase and Parkinson disease

  2010cited by this paper
• Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.

  2010cited by this paper
• DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease.

  2010cited by this paper
• Parkinson Disease-associated DJ-1 Is Required for the Expression of the Glial Cell Line-derived Neurotrophic Factor Receptor RET in Human Neuroblastoma Cells*

  2010cited by this paper
• The particular relationship between Parkinson’s disease and malignancy: a focus on skin cancers

  2009cited by this paper
• Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis

  2009cited by this paper
• Endothelin-1 inhibits prostate cancer growth in vivo through vasoconstriction of tumor-feeding arterioles

  2009cited by this paper
• Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies

  2009cited by this paper
• Vascular permeability in cardiovascular disease and cancer

  2008cited by this paper
• aPKC enables development of zonula adherens by antagonizing centripetal contraction of the circumferential actomyosin cables

  2008cited by this paper
• Prevalence of comorbidity of chronic diseases in Australia

  2008cited by this paper
• The proNGF-p75NTR-sortilin signalling complex as new target for the therapeutic treatment of Parkinson's disease.

  2008cited by this paper
• The endothelin axis in cancer: the promise and the challenges of molecularly targeted therapy.

  2008cited by this paper
• Recognition of DNA double strand breaks by the BRCA1 tumor suppressor network

  2008cited by this paper
• The role of the DNA damage response in neuronal development, organization and maintenance.

  2008cited by this paper
• Neurotrophins and their receptors stimulate melanoma cell proliferation and migration.

  2008cited by this paper
• Expression of Neurotensin and its Receptors in Pituitary Adenomas

  2008cited by this paper
• Iron Accumulation with Age, Oxidative Stress and Functional Decline

  2008cited by this paper
• Clinical trials for neuroprotection in Parkinson's disease: overcoming angst and futility?

  2007cited by this paper
• Blood–brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons

  2007cited by this paper
• Blood–Brain Barrier Pathology in Alzheimer's and Parkinson's Disease: Implications for Drug Therapy

  2007cited by this paper
• Regulation of endothelial barrier function during flow-induced conversion to an arterial phenotype.

  2007cited by this paper
• Inactivation of aPKCλ results in the loss of adherens junctions in neuroepithelial cells without affecting neurogenesis in mouse neocortex

  2006cited by this paper
• Interneurite affinity is regulated by heterophilic nectin interactions in concert with the cadherin machinery

  2006cited by this paper
• Tumours and tremors: how PTEN regulation underlies both

  2006cited by this paper
• To die or grow: Parkinson's disease and cancer.

  2005cited by this paper
• Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.

  2005cited by this paper
• Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer The Women ’ s Health Study : A Randomized Controlled Trial

  2005cited by this paper
• Pharmacologic manipulation of the ataxia-telangiectasia mutated gene product as an intervention in age-related disease.

  2005cited by this paper
• Stability of dendritic spines and synaptic contacts is controlled by alpha N-catenin.

  2004cited by this paper
• Gene regulation and DNA damage in the ageing human brain

  2004cited by this paper
• Exploiting tumour hypoxia in cancer treatment

  2004cited by this paper
• Atypical cancer pattern in patients with Parkinson's disease

  2004cited by this paper
• A renaissance for SRC

  2004cited by this paper
• Stability of dendritic spines and synaptic contacts is controlled by αN-catenin

  2004cited by this paper
• The aging brain: less neurons could be better.

  2003cited by this paper
• Nectins and nectin‐like molecules: Roles in cell adhesion, migration, and polarization

  2003cited by this paper
• Adherens junctions and tight junctions are regulated via different pathways by progastrin in epithelial cells

  2003cited by this paper
• Prevalence, expenditures, and complications of multiple chronic conditions in the elderly.

  2002cited by this paper
• A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

  2002cited by this paper
• Calcium Modulation of Adherens and Tight Junction Function: A Potential Mechanism for Blood-Brain Barrier Disruption After Stroke

  2002cited by this paper
• Involvement of the neurotensin receptor subtype NTR3 in the growth effect of neurotensin on cancer cell lines

  2001cited by this paper
• Cardiac Sympathetic Denervation in Parkinson Disease

  2000cited by this paper
• Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study.

  1999cited by this paper
• Tocopherol‐mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement

  1999cited by this paper
• Genetic analysis of BRCA1 function in a defined tumor cell line.

  1999cited by this paper
• Selective loss of dopaminergic nigro-striatal neurons in brains of Atm-deficient mice.

  1998cited by this paper
• Neurons in the cerebral cortex are most susceptible to DNA‐damage in aging rat brain

  1996cited by this paper
• Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

  1994cited by this paper
• Oxy-radicals and cancer.

  1994cited by this paper
• An open trial of high-dosage antioxidants in early Parkinson's disease.

  1991cited by this paper
• Multiple primary melanoma following administration of levodopa.

  1972cited by this paper
• The Application of Clinical Genetics Dovepress Genetic Basis of Parkinson's Disease: Inheritance, Penetrance, and Expression

  year unknowncited by this paper

• Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s disease

  2020cites this paper
• Urine proteome changes in an α-synuclein transgenic mouse model of Parkinson’s disease

  2020cites this paper